Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity |
Investigator |
Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Exploring the Neurobiology of the Premonitory Phase of Migraine Preclinically | Contract | $149,875.50 | Research | Caroline Kopruszinski | Pharmacology | Amgen | 01/2020 |
| The Dynamic Angiogenic Network Underpinning Coronary Artery Disease | Grant | $275,000.00 | Research | Casey Romanoski | Cellular & Molecular Medicine | Harold S. Geneen Charitable Trust | 12/2020 |
| The Positive Roles of Lysine Deacetylase Complexes in Regulating Transcriptional Dynamics | Grant | $1,321,692.00 | Research | Catharine Smith | Pharmacology and Toxicology | National Institute of General Medical Sciences | 12/2020 |
| COVID-19 Vaccination Border Region Partnership | Contract | $99,999.99 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Prac & Trans Rsch | Arizona Department of Health Services | 06/2022 |
| Mexico Section USMBHC Mobile Health Clinic | Contract | $20,000.00 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Prac & Trans Rsch | The United States-Mexico Border Health Commission | 01/2021 |
| Primary Prevention Mobile Unit - Mobile MAT Clinics | Grant | $31,635.00 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Prac & Trans Rsch | University of Arizona Foundation | 11/2020 |
| Mobile Vaccine Clinic | Contract | $250,000.00 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Prac & Trans Rsch | Maricopa County Department of Public Health | 04/2021 |
| Ventanilla de Salud-Phoenix | Contract | $672,592.28 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Prac & Trans Rsch | Consulado General de Mexico en Phoenix (Mexico) | 01/2022 |
| Yuma County Contact Tracing | Contract | $252,435.00 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Pract & Trans Rsch | Yuma County Public Health Services District | 07/2020 |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... | Contract | $1,278,228.50 | Clinical Trial | Charles Hsu | Radiation Oncology | Astrazeneca | 08/2020 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... | Contract | $42,626.00 | Clinical Trial | Charles Hsu | Cancer Center Division | PSI Pharma Support America, Incorporated | 01/2020 |
| Project Site Manager Transition | Contract | $26,070.00 | Research | Chaur-Dong Hsu | Obstetrics and Gynecology | Wayne State University | 06/2022 |
| Molecular, Functional, and Microstructural Imaging of Cervical Remodeling Biomarkers | Grant | $20,038.00 | Research | Chaur-Dong Hsu | Obstetrics and Gynecology | Wayne State University | 09/2021 |
| Patient-Specific iPSCs-Derived Vascularized Organoids for Investigating Differential Susceptibility to E-cigarette | Fellowship | $135,352.00 | Research Training | Chen-wei Liu | COM Phx Basic Medical Sci | American Heart Association, Incorporated | 01/2020 |
| Circulating Exosomes With Lung Self-Antigens (Collagen V, K1 Tubulin) and Tumor Suppressor Gene, Liver Kinase B1, As Biomarkers for Early Detection of Lung Transplant Recipients at Risk for Chronic? | Grant | $30,605.00 | Research | Chengcheng Hu | Epidemiology and Biostatistics | Saint Joseph's Hospital and Medical Center | 07/2022 |
| Mechanisms for Intracranial Aneurysm Rupture | Grant | $52,190.00 | Research | Chengcheng Hu | Epidemiology and Biostatistics | Saint Joseph's Hospital and Medical Center | 06/2020 |
| Personal Best: A Program to Enhance Emotional Intelligence and Coaching Skills in Graduate Medical Education | Grant | $30,000.00 | Other Sponsored Activity | Cheryl Omalley | COM Phx Campus Administration | American Medical Association | 10/2021 |
| A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients With Rheumatoid Arthritis: The RAPRO PRagmatic Trial (RA-PROPR) | Contract | $35,112.00 | Clinical Trial | Chian Kwoh | Arthritis Center-Research | University of Alabama at Birmingham | 01/2022 |
| A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients with Diffuse Cutaneous Systemic Sclerosis or Systemic Sclerosis-Associated... | Contract | $55,928.00 | Clinical Trial | Chian Kwoh | Arthritis Center-Research | Cumberland Pharmaceuticals, Incorporated | 07/2020 |
| Healthy Knee Aging Vs. Osteoarthritis in Three Large Diverse Cohorts: What Is the Clinical Relevance of Structural Changes Seen on Radiographs? | Grant | $2,155,279.00 | Research | Chian Kwoh | Arthritis Center-Research | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 10/2021 |
| A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... | Contract | $314,050.00 | Clinical Trial | Chian Kwoh | Arthritis Center-Research | IQVIA RDS Inc. | 03/2020 |
| Assessing the Impact of Greening and Upgrading Playgrounds in New York City on Students Academic and Health Outcomes and on Community Health Measures | Grant | $303,972.00 | Research | Chris Chaeha Lim | Community Environment & Policy | Robert Wood Johnson Foundation | 02/2021 |
| Arrest Respiratory Failure Due to Pneumonia (ARREST PNEUMONIA) | Cooperative Agreement | $458,244.00 | Research | Christian Bime | Medicine | Stanford University | 05/2020 |
| In Vivo Screening of Candidate Therapeutic Antibodies in a Preclinical Swine Model of Acute Lung Injury | Contract | $50,379.00 | Research | Christian Bime | Medicine | Aqualung Therapeutics, Corp. | 04/2020 |
| A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS) | Contract | $167,627.92 | Clinical Trial | Christian Bime | Medicine | Kinevant Sciences, Inc. | 10/2020 |